These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7561181)

  • 1. Review: granulocyte colony-stimulating factor--role and relationships in infectious diseases.
    Dale DC; Liles WC; Summer WR; Nelson S
    J Infect Dis; 1995 Oct; 172(4):1061-75. PubMed ID: 7561181
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use of granulocyte colony-stimulating factor in infectious diseases.
    Gaviria JM; Garrido SM; Root RK
    Curr Clin Top Infect Dis; 2001; 21():302-22. PubMed ID: 11572156
    [No Abstract]   [Full Text] [Related]  

  • 3. Colony-stimulating factors in the prevention and management of infectious diseases.
    Page AV; Liles WC
    Infect Dis Clin North Am; 2011 Dec; 25(4):803-17. PubMed ID: 22054757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony-stimulating factor: its potential role in infectious disease.
    Hartung T
    AIDS; 1999; 13 Suppl 2():S3-9. PubMed ID: 10596675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of granulocyte colony-stimulating factor in preclinical models of infection and acute inflammation.
    Marshall JC
    Shock; 2005 Dec; 24 Suppl 1():120-9. PubMed ID: 16374383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis.
    Weiss M; Moldawer LL; Schneider EM
    Blood; 1999 Jan; 93(2):425-39. PubMed ID: 9885204
    [No Abstract]   [Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on the use of cytokines in the management of infectious complications of cancer.
    Roilides E; Pizzo PA
    Clin Infect Dis; 1993 Nov; 17 Suppl 2():S385-9. PubMed ID: 7506061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte colony-stimulating factors as therapeutic agents.
    Donahue RE; Clark SC
    Immunol Ser; 1992; 57():637-49. PubMed ID: 1380310
    [No Abstract]   [Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor for severe pneumonia: what do we do when the best laid plans for men (and mice and rats...) fail?
    Niederman MS
    Crit Care Med; 2003 Feb; 31(2):635-7. PubMed ID: 12576978
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical studies of granulocyte colony stimulating factor (G-CSF).
    Scarffe JH; Kamthan A
    Cancer Surv; 1990; 9(1):115-30. PubMed ID: 1703454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.
    Wislez M; Fleury-Feith J; Rabbe N; Moreau J; Cesari D; Milleron B; Mayaud C; Antoine M; Soler P; Cadranel J
    Am J Pathol; 2001 Oct; 159(4):1423-33. PubMed ID: 11583970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor and modulation of inflammatory cells in sepsis.
    Nelson S; Bagby GJ
    Clin Chest Med; 1996 Jun; 17(2):319-32. PubMed ID: 8792069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
    Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
    Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Granulocyte colony-stimulating factor: biologic effects and possibilities of therapeutic use].
    Jovanović-Mićić D; Beleslin DB; Samardzić R; Bosnjak S
    Med Pregl; 1994; 47(3-4):102-4. PubMed ID: 7537846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of fecal peritoneal infection in mice by colony-stimulating factors.
    Barsig J; Bundschuh DS; Hartung T; Bauhofer A; Sauer A; Wendel A
    J Infect Dis; 1996 Oct; 174(4):790-9. PubMed ID: 8843218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant methionyl human granulocyte colony-stimulating factor for the prevention and treatment of non-neutropenic infectious diseases.
    Daifuku R; Andresen J; Morstyn G
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():91-7. PubMed ID: 7691789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The discovery, development and clinical applications of granulocyte colony-stimulating factor.
    Dale DC
    Trans Am Clin Climatol Assoc; 1998; 109():27-36; discussion 36-8. PubMed ID: 9601125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [More efforts should be made to improve the level of diagnosis and treatment of infectious diseases of newborn infants].
    Huang DM; Tong XM
    Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):881-3. PubMed ID: 14723803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.